Wenge Guo

730 total citations
32 papers, 446 citations indexed

About

Wenge Guo is a scholar working on Statistics and Probability, Management Science and Operations Research and Molecular Biology. According to data from OpenAlex, Wenge Guo has authored 32 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Statistics and Probability, 16 papers in Management Science and Operations Research and 10 papers in Molecular Biology. Recurrent topics in Wenge Guo's work include Statistical Methods in Clinical Trials (21 papers), Optimal Experimental Design Methods (16 papers) and Statistical Methods and Bayesian Inference (10 papers). Wenge Guo is often cited by papers focused on Statistical Methods in Clinical Trials (21 papers), Optimal Experimental Design Methods (16 papers) and Statistical Methods and Bayesian Inference (10 papers). Wenge Guo collaborates with scholars based in United States, China and Hungary. Wenge Guo's co-authors include Sanat K. Sarkar, Joseph P. Romano, Shyamal D. Peddada, Marepalli B. Rao, Bin Yu, Helmut Finner, Hong‐Min Liu, Bing Zhao, Peng Geng and M. Bhaskara Rao and has published in prestigious journals such as Journal of the American Statistical Association, Biometrics and Biometrika.

In The Last Decade

Wenge Guo

30 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenge Guo United States 14 160 134 89 64 28 32 446
Jyothi Subramanian India 9 299 1.9× 77 0.6× 38 0.4× 28 0.4× 58 2.1× 9 602
Xiaodong Luo United States 16 129 0.8× 303 2.3× 8 0.1× 54 0.8× 38 1.4× 60 755
Paloma Maı́n Spain 11 192 1.2× 67 0.5× 12 0.1× 8 0.1× 59 2.1× 24 454
Peter Müller United States 10 70 0.4× 296 2.2× 7 0.1× 133 2.1× 12 0.4× 24 534
Suntara Cahya United States 10 117 0.7× 17 0.1× 8 0.1× 37 0.6× 39 1.4× 14 278
Amanda Wilson United Kingdom 9 199 1.2× 76 0.6× 10 0.1× 9 0.1× 46 1.6× 33 805
Ning Tang China 5 287 1.8× 11 0.1× 11 0.1× 36 0.6× 13 0.5× 11 452
Zhaoling Meng United States 9 131 0.8× 85 0.6× 5 0.1× 13 0.2× 6 0.2× 21 356
Chanchala Kaddi United States 10 175 1.1× 31 0.2× 7 0.1× 17 0.3× 27 1.0× 33 550

Countries citing papers authored by Wenge Guo

Since Specialization
Citations

This map shows the geographic impact of Wenge Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenge Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenge Guo more than expected).

Fields of papers citing papers by Wenge Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenge Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenge Guo. The network helps show where Wenge Guo may publish in the future.

Co-authorship network of co-authors of Wenge Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Wenge Guo. A scholar is included among the top collaborators of Wenge Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenge Guo. Wenge Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Wenge, Min Li, Ting Hu, et al.. (2022). Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives. Bioorganic & Medicinal Chemistry Letters. 76. 129020–129020. 5 indexed citations
2.
Wang, Bo, Bing Zhao, L. Pang, et al.. (2017). LPE-1, an orally active pyrimidine derivative, inhibits growth and mobility of human esophageal cancers by targeting LSD1. Pharmacological Research. 122. 66–77. 27 indexed citations
3.
Li, Zhonghua, Xue‐Qi Liu, Taoqian Zhao, et al.. (2017). Design, synthesis and preliminary antiproliferative activity studies of new diheteroaryl thioether derivatives. Bioorganic & Medicinal Chemistry Letters. 27(18). 4377–4382. 11 indexed citations
4.
Grandhi, Anjana, Wenge Guo, & Shyamal D. Peddada. (2016). A multiple testing procedure for multi-dimensional pairwise comparisons with application to gene expression studies. BMC Bioinformatics. 17(1). 104–104. 9 indexed citations
5.
Li, Zhonghua, Dongxiao Yang, Peng Geng, et al.. (2016). Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents. European Journal of Medicinal Chemistry. 124. 967–980. 67 indexed citations
6.
Hu, Shaoyan, Xiaoyan Yang, Mingying Zhang, et al.. (2016). High expression of <em>S100A8</em> gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway. OncoTargets and Therapy. Volume 9. 4887–4899. 25 indexed citations
7.
Guo, Wenge & Joseph P. Romano. (2015). On stepwise control of directional errors under independence and some dependence. Journal of Statistical Planning and Inference. 163. 21–33. 12 indexed citations
8.
Guo, Wenge, et al.. (2015). On generalized fixed sequence procedures for controlling the FWER. Statistics in Medicine. 34(30). 3968–3983.
9.
Sarkar, Sanat K., Jingjing Chen, & Wenge Guo. (2013). Multiple Testing in a Two-Stage Adaptive Design With Combination Tests Controlling FDR. Journal of the American Statistical Association. 108(504). 1385–1401. 9 indexed citations
10.
Guo, Wenge, et al.. (2012). Analysis of high dimensional data using pre-defined set and subset information, with applications to genomic data. BMC Bioinformatics. 13(1). 177–177. 2 indexed citations
11.
Guo, Wenge & M. Bhaskara Rao. (2010). On stepwise control of the generalized familywise error rate. Electronic Journal of Statistics. 4(none). 2 indexed citations
12.
Guo, Wenge, Sanat K. Sarkar, & Shyamal D. Peddada. (2009). Controlling False Discoveries in Multidimensional Directional Decisions, with Applications to Gene Expression Data on Ordered Categories. Biometrics. 66(2). 485–492. 39 indexed citations
13.
Sarkar, Sanat K. & Wenge Guo. (2009). On a generalized false discovery rate. The Annals of Statistics. 37(3). 17 indexed citations
14.
Guo, Wenge. (2009). A note on adaptive Bonferroni and Holm procedures under dependence. Biometrika. 96(4). 1012–1018. 24 indexed citations
15.
Guo, Wenge & Shyamal D. Peddada. (2008). Adaptive Choice of the Number of Bootstrap Samples in Large Scale Multiple Testing. Statistical Applications in Genetics and Molecular Biology. 7(1). Article13–Article13. 14 indexed citations
16.
Guo, Wenge & M. Bhaskara Rao. (2008). On optimality of the Benjamini–Hochberg procedure for the false discovery rate. Statistics & Probability Letters. 78(14). 2024–2030. 14 indexed citations
17.
18.
Guo, Wenge & Marepalli B. Rao. (2008). On control of the false discovery rate under no assumption of dependency. Journal of Statistical Planning and Inference. 138(10). 3176–3188. 26 indexed citations
19.
Guo, Wenge & Joseph P. Romano. (2007). A Generalized Sidak-Holm Procedure and Control of Generalized Error Rates under Independence. Statistical Applications in Genetics and Molecular Biology. 6(1). Article3–Article3. 47 indexed citations
20.
Guo, Wenge, et al.. (2001). Combinatorial Trading Mechanism for Task Allocation.. 175–180. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026